EventsPacientsATMPsCell therapyGen TherapyDrug DiscoveryCTGCTNICGregor Cuzak 23 June 2026 CTGCT and the National Institute of Chemistry presented gene and cell therapies to students of Gimnazija Jesenice. On 12 June 2026, representatives of the National Institute of Chemistry and CTGCT visited Gimnazija Jesenice, where they presented modern biological medicines and the development of gene and cell therapies to third-year students. More
EventsPacientsCTGCTNICRodrigo Ortiz 22 May 2026 Event Date: 13 May 2026 do: 13 May 2026 • CTGCT at BioFair 5.0: connecting with the next generation of experts in gene and cell therapy On the 13th of May, part of the CTGCT team attended BioFair 5.0 the largest career event for students in the field of life sciences in Slovenia, organized by the non-profit student association BEST ... More
ArticlesPacientsCTGCTGregor Cuzak 18 February 2025 Hugs for rare The 28th of February is approaching which is the Day of Rare diseases. Hugs are being collected in 7 countries to raise awareness of the importance of everyone working together to defeat rare diseases. More
ATMPsBusiness ModelEconomicsCTGCTUCLGregor Cuzak 12 February 2025 Introduction to IP and commercialisation – by UCL The workshop took place on February 3d and was attended by the CTGCT advanced partners only. It provided an in-depth discussion on Intellectual Property (IP) and the process of commercializing research findings. The session ... More
ArticlesMedia ReleasesResearchersATMPsCell therapyGen TherapyResearchCharite BerlinCTGCTNICTUDUCLUMCUtrechtRodrigo Ortiz 6 December 2024 CTGCT’s Innovation Report on Gene and Cell Therapy We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ) More
EventsCliniciansPacientsResearchersATMPsCell therapyGen TherapyRegulationCTGCTNICRodrigo Ortiz 20 September 2024 Bridging Gaps: ERN ITHACA and SATB2 Europe Visit the Center for Technologies of Gene and Cell Therapy The CTGCT hosted representatives from ERN ITHACA and SATB2 Europe to discuss collaborative efforts in rare disease research and treatment. The meeting focused on developing innovative therapies and strengthening connections between researchers, clinicians, and ... More
InterviewResearchersDatamanagementDrug DiscoveryResearchCTGCTNICGregor Cuzak 27 June 2024 Interview with Shivang Khandewal – collaborator of NIC and CTNNB1 Originally from India, Shivang Khandelwal is presently engaged in advanced studies at the Hebrew University of Jerusalem. His primary research focus is on PCDH19 cluster epilepsy, a neurodevelopmental and neuropsychiatric disorder. He is deeply ... More
ArticlesCliniciansPacientsResearchersDrug DiscoveryMarketaccessRegulationResearchCTGCTGregor Cuzak 27 June 2024 Bespoke Gene Therapy Consortium – cooperation for rare disease therapies At the Bespoke Gene Therapy Consortium (BGTC, website), a consortium for the treatment of rare monogenetic diseases, they aim to treat neglected diseases with a very small number of patients with a focus solely ... More
EventsCliniciansPacientsResearchersGen TherapyGMPClinic studyDatamanagementDrug DiscoveryEthicalcommitteeInvestmentLaboratoryLogisticsManufacturing ProcessModalitetadelovanjazdravilaPharmacodynamicsPharmacokineticsPre ClinicalRaw MaterialRegulationResearchCTGCTNICGregor Cuzak 26 June 2024 Event Date: 14 June 2024 • 09:00 − 17:00 CTNNB1 Conference – One Year to Cure One year to cure is the goal shared by parents of children with the CTNNB1 Syndrome rare disease. Out of approximately 400 known cases worldwide, 82 families with children gathered at the conference in ... More
EventsResearchersCell therapyResearchCTGCT 8 September 2023 Event Date: 15 May 2024 • 10:00 − 16:00 STA Live: CTGCT kick-off meeting broadcast Introductory meeting at the launch of the Centre for Gene and Cellular Therapy Technologies (CTGCT) project, where new, personalized treatments will be developed. More
